加载中…
这里每家公司都经过同样的五项成长与现金创造检验。它描述的是这个行业今天申报出来的样子——而不是该买其中哪一家。
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | C | US$50.4B | US$43.21 | 100.49 | US$17.2B | 2.9% |
| HLN | Haleon plc | B+ | US$40.7B | US$9.09 | 18.33 | US$14.8B | 15.1% |
| ZTS | Zoetis Inc. | C+ | US$33.5B | US$82.57 | 13.92 | US$9.5B | 26.4% |
| TAK | Takeda Pharmaceutical Company Limited | A | US$33.5B | US$20.86 | 48.79 | US$29.8B | 0.9% |
| UTHR | United Therapeutics Corporation | C+ | US$25.4B | US$595.58 | 22.48 | US$3.2B | 38.6% |
| VTRS | VIATRIS INC. | D | US$24.1B | US$21.06 | — | US$14.7B | -23.9% |
| NBIX | NEUROCRINE BIOSCIENCES, INC. | A+ | US$17.6B | US$174.35 | 25.87 | US$3.7B | 19.0% |
| ELAN | Elanco Animal Health Incorporated | A | US$13.2B | US$26.48 | — | US$5.1B | -2.9% |
| RDY | DR. REDDY’S LABORATORIES LIMITED | B | US$12.4B | US$14.83 | 20.77 | US$3.5B | 4.4% |
| KNSA | Kiniksa Pharmaceuticals International, plc | A+ | US$8.1B | US$95.80 | 73.13 | US$946M | 11.6% |
| ALKS | Alkermes plc. | C | US$8B | US$47.88 | — | US$1.8B | -0.0% |
| AMRX | Amneal Pharmaceuticals, Inc. | C | US$7.6B | US$21.72 | 51.71 | US$3.2B | 4.2% |
| LNTH | LANTHEUS HOLDINGS, INC. | B+ | US$6.6B | US$101.58 | 25.08 | US$1.6B | 17.3% |
| LQDA | LIQUIDIA CORPORATION | A | US$5B | US$55.19 | — | US$621.9M | -15.1% |
| HIMS | HIMS & HERS HEALTH, INC. | C- | US$4.9B | US$20.81 | — | US$2.9B | -6.7% |
| AMLX | Amylyx Pharmaceuticals, Inc. | D | US$4.1B | US$31.78 | — | US$0.00 | — |
| BHC | Bausch Health Companies Inc. | A | US$3.1B | US$8.35 | — | US$11.1B | -7.6% |
| XERS | XERIS BIOPHARMA HOLDINGS, INC. | F- | US$3B | US$16.51 | — | US$368.3M | -1.8% |
| RGC | REGENCELL BIOSCIENCE HOLDINGS LIMITED | 未评级 | US$2.7B | US$5.45 | — | — | — |
| HCM | HutchMED (China) LIMITED | D | US$2.6B | US$15.04 | — | US$549.1M | 3.3% |
| PRGO | Perrigo Company plc | F- | US$2.3B | US$16.56 | — | US$4.1B | -43.3% |
| TRLV | TRULIEVE CANNABIS CORP. | F | US$2.3B | US$11.24 | — | US$1.1B | -41.3% |
| PBH | PRESTIGE CONSUMER HEALTHCARE INC. | C+ | US$2.1B | US$44.17 | 13.63 | US$1.2B | 13.3% |
| ETON | ETON PHARMACEUTICALS, INC. | A+ | US$2B | US$68.42 | — | US$141.1M | 35.3% |
| BCRX | BIOCRYST PHARMACEUTICALS, INC. | B | US$2B | US$7.65 | — | US$961.5M | -37.4% |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | B | US$1.7B | US$29.42 | — | US$865.1M | -5.1% |
| ANIP | ANI PHARMACEUTICALS, INC | B+ | US$1.5B | US$71.23 | 14.22 | US$1B | 11.2% |
| ALVO | ALVOTECH | B | US$1.5B | US$4.93 | 49.25 | US$586.3M | 4.8% |
| PCRX | PACIRA BIOSCIENCES, INC. | B | US$1.5B | US$36.47 | 39.22 | US$743.3M | 5.1% |
| PAHC | Phibro Animal Health Corporation | B | US$1.4B | US$35.13 | 14.00 | US$1.5B | 6.7% |
| CRON | CRONOS GROUP INC. | A | US$1.3B | US$3.46 | 20.32 | US$206.2M | 28.0% |
| AMPH | Amphastar Pharmaceuticals, Inc. | B+ | US$1.2B | US$28.61 | 13.06 | US$745.8M | 13.3% |
| HROW | Harrow, Inc. | D- | US$1.1B | US$29.30 | — | US$303.3M | -9.4% |
| BGM | BGM Group Ltd | F- | US$985.4M | US$8.70 | — | US$47.9M | -44.2% |
| IRWD | IRONWOOD PHARMACEUTICALS INC | C+ | US$804.6M | US$4.86 | 5.40 | US$400.3M | 37.4% |
| COLL | Collegium Pharmaceutical, Inc. | B | US$770.5M | US$24.80 | 24.80 | US$815.2M | 4.7% |
| TKNO | ALPHA TEKNOVA, INC. | B- | US$541.6M | US$8.61 | — | US$46M | -34.8% |
| EOLS | EVOLUS, INC. | B | US$492.1M | US$7.44 | — | US$325.5M | -9.6% |
| KMDA | KAMADA LTD | C+ | US$469.6M | US$8.14 | 18.93 | US$196.9M | 13.6% |
| AQST | Aquestive Therapeutics, Inc. | D | US$449.3M | US$3.58 | — | US$48.8M | -162.3% |
| TLRY | Tilray Brands, Inc. | C- | US$385M | US$2.61 | — | US$963.1M | -17.1% |
| EBS | EMERGENT BIOSOLUTIONS INC. | D | US$310.3M | US$6.04 | — | US$649.1M | -40.2% |
| EVO | Evotec SE | F- | US$304.9M | US$1.72 | — | US$836.2M | -26.0% |
| ACB | AURORA CANNABIS INC | D- | US$280.9M | US$5.05 | 176.32 | US$225.8M | -29.9% |
| BIOA | BIOAGE LABS, INC. | F- | US$268.9M | US$5.85 | — | US$8.6M | -1,253.6% |
| CGC | Canopy Growth Corporation | C- | US$256.3M | US$0.61 | — | US$219.2M | -87.0% |
| LFCR | LIFECORE BIOMEDICAL, INC. | F | US$242.4M | US$6.40 | — | US$128.9M | -30.0% |
| SIGA | Siga Technologies INC | F | US$225.6M | US$3.14 | — | US$52.4M | 1.3% |
| INCR | INTERCURE LTD. | C- | US$219.8M | US$4.02 | — | US$86.4M | -13.2% |
| ADCT | ADC Therapeutics SA | C | US$203.6M | US$1.60 | — | US$84.9M | -95.7% |
| ANIK | Anika Therapeutics, Inc. | B- | US$186.3M | US$13.91 | — | US$123.4M | -1.4% |
| GLAS | Glass House Brands Inc. | F- | US$165.5M | US$1.90 | — | US$152.9M | -33.7% |
| AKBA | AKEBIA THERAPEUTICS, INC. | D | US$158M | US$0.57 | — | US$197.2M | -22.6% |
| ORGO | ORGANOGENESIS HOLDINGS INC. | F- | US$136.3M | US$1.05 | — | US$352M | -38.4% |
| DERM | Journey Medical Corp | C- | US$125.7M | US$4.46 | — | US$68.2M | -9.0% |
| CRDL | Cardiol Therapeutics Inc. | 未评级 | US$100.8M | US$1.01 | — | — | — |
| CPIX | Cumberland Pharmaceuticals Inc. | F- | US$94.8M | US$6.33 | — | US$39.9M | -27.4% |
| INM | INMED PHARMACEUTICALS INC. | F- | US$85.5M | US$15.56 | — | US$4.5M | -292.1% |
| OGI | ORGANIGRAM HOLDINGS INC. | C- | US$81.3M | US$0.85 | — | US$185.5M | -9.6% |
| ZYBT | Zhengye Biotechnology Holding Limited | D | US$72.3M | US$1.53 | — | US$17.5M | -60.0% |
| CTOR | Citius Oncology, Inc. | 未评级 | US$51.7M | US$0.56 | — | — | — |
| SCYX | SCYNEXIS INC | F- | US$34.1M | US$3.43 | — | US$18.9M | -53.5% |
| RMTI | ROCKWELL MEDICAL, INC. | B- | US$28.7M | US$7.13 | — | US$72.6M | -7.8% |
| CPHI | CHINA PHARMA HOLDINGS, INC. | D- | US$22.7M | US$0.53 | — | US$3.9M | -114.3% |
| TXMD | TherapeuticsMD, Inc. | F- | US$21.4M | US$1.85 | — | US$3.3M | -6.6% |
| AYTU | AYTU BIOPHARMA, INC. | C | US$19.7M | US$1.82 | — | US$57.6M | -24.8% |
| RDHL | REDHILL BIOPHARMA LTD. | F | US$17.9M | US$0.40 | — | -US$3.7M | -72.5% |
| TLPH | TALPHERA, INC. | D- | US$15M | US$1.05 | — | US$1K | -1,465,800.0% |
| BFRI | Biofrontera Inc. | B- | US$13.9M | US$0.93 | — | US$46.2M | -13.8% |
| SBFM | Sunshine Biopharma Inc. | D- | US$10.7M | US$2.76 | — | US$35.3M | -16.5% |
| CABR | Caring Brands, Inc. | F- | US$9.2M | US$0.88 | — | US$4.2K | -183,255.2% |
| IMCC | IM Cannabis Corp. | D | US$7.2M | US$0.56 | — | US$32.8M | -40.1% |
| SNOA | SONOMA PHARMACEUTICALS, INC. | C- | US$6.2M | US$1.23 | — | US$23.5M | -7.6% |
| SHPH | SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | 未评级 | US$5.4M | US$5.32 | — | — | — |
| GELS | Gelteq Limited | D- | US$4M | US$0.43 | — | US$116.4K | -4,011.9% |
| APUS | APIMEDS PHARMACEUTICALS US, INC. | 未评级 | US$3.4M | US$2.28 | — | — | — |
| SXTC | China SXT Pharmaceuticals, Inc. | F- | US$2.8M | US$2.89 | — | US$1.1M | -545.2% |
| YCBD | cbdMD, Inc. | D- | US$1.6M | US$0.39 | — | US$20.9M | -13.8% |
| IXHL | Incannex Healthcare Inc. | F- | US$993.5K | US$1.98 | — | US$0.00 | — |
| UPC | Universe Pharmaceuticals INC | D- | US$907K | US$1.61 | — | US$17.9B | -20.6% |
| PRFX | PRF Technologies Ltd. | B- | US$629.5K | US$0.76 | — | US$17K | -29,541.2% |
| AKAN | Akanda Corp. | F | US$50.4K | US$0.73 | — | US$258.1K | -19,775.5% |
| INDV | Indivior Pharmaceuticals, Inc. | A | — | US$28.15 | — | US$1.4B | 32.8% |
| OPTH | Optimi Health Corp. | 未评级 | — | US$2.19 | — | — | — |
基本面来自 SEC 申报文件，价格来自最近一次行情更新。可按任意列排序；没有数值的公司在两个方向都排在末尾。
按市值从大到小排序；点击任意列可重新排序。没有数值的公司在两个方向都排在末尾，因为市盈率缺失意味着亏损，而不是便宜。这里没有任何内容构成推荐。